Trials / Completed
CompletedNCT02084290
Evaluating a Shared Decision Making Program for Crohn's Disease
Evaluating a Prediction Tool and Decision Aid for Patients With Crohn's Disease
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 204 (actual)
- Sponsor
- Dartmouth-Hitchcock Medical Center · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Specific Aim: Study the impact of the Crohn's Disease Shared Decision Making Program on patients' treatment choice, persistence with chosen therapy, decision quality, cost of care, and outcomes Hypothesis: The Crohn's Disease Shared Decision Making Program will help patients understand which treatments are right for them and will lead to a higher acceptance of appropriate therapy, improved persistence with chosen therapy, lower costs and improved clinical outcomes. To accomplish this aim, Investigators will perform a randomized controlled trial to: 1. Determine how the shared decision making program influences patients' choice of therapy 2. Evaluate how the shared decision making program affects persistence with chosen therapy 3. Determine how the shared decision making program affects decision quality 4. Determine how the shared decision making program influences cost of care and clinical outcomes Expected Outcome and Impact: Investigators expect that this program will influence patients' choice of therapy, persistence with their preferred therapy, and lead to improved clinical outcomes. Investigators believe that this product can be successfully operationalized in the clinic to establish a new paradigm of how providers can communicate personalized treatment options to patients across a broad range of diseases.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Shared Decision Making Program | This study is cluster randomized by study-site, Subjects enrolled at intervention sites will access an educational program and risk prediction tool. Their decisions about treatments will be compared to subjects that did not view the educational program or risk prediction tool. |
Timeline
- Start date
- 2014-03-01
- Primary completion
- 2017-08-31
- Completion
- 2018-12-31
- First posted
- 2014-03-11
- Last updated
- 2019-02-07
Locations
14 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT02084290. Inclusion in this directory is not an endorsement.